(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were slightly lower on Monday after a rally that pushed the S&P 500 closer to its record high as investors turned cautious ahead of the U.S. Federal Reserve meeting this week. Dow Jones industrial average futures were down 0.28 percent at 17,867, S&P 500 futures were down 0.34 percent at 2,079 and Nasdaq 100 futures were down 0.29 percent at 4,452.75.
** TRIBUNE PUBLISHING CO, Friday close $7.52, +57.05 pct premarket
** GANNETT CO, Friday close $15.77, -0.44 pct premarket
The Company is to be bought by Gannett, the publisher of USA Today, for $815 million, including the assumption of debt.
** SAREPTA THERAPEUTICS INC, Friday close $14.95, +7.02 pct premarket
Sarepta’s muscle wasting drug got a new lease of life on Friday after staff at the U.S. Food and Drug Administration made it necessary that an independent panel of experts recommend on Monday on whether the drug should be approved or not. Sarepta’s stock surged 36 percent on Friday. They closed down about 44 percent on Thursday, when the staff reviewers issued a scathing review on the drug.
** PERRIGO CO PLC, Friday close $121.35, -12.66 pct premarket
** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Friday close $35.98
Perrigo lowers full year 2016 adjused profit forecast to $8.20-$8.60, from $9.50-$9.80. Valeant Pharmaceuticals International Inc names Perrigo’s CEO, Papa, as its new CEO; Papa expected to join the company by early May. Perrigo also says it has identified indicators of impairment related to its Branded Consumer Healthcare business.
** XEROX CORP, Friday close $11.17, -6.89 pct premarket
The printer and copier maker reported a 4.2 percent fall in its quarterly revenue, hurt by a strong dollar and lower sales of printers and copiers.
** BALL CORP, Friday close $75.84, +0.00 pct premarket
The Beverage can makers and Rexam Plc will sell some of their assets to European packaging maker Ardagh Group in a deal worth $3.42 billion, as they seek antitrust clearance for their planned merger.
** DEPOMED INC, Friday close $17.54, -0.23 pct premarket
The drug developer said on Monday Starboard Value LP has 30 days to request for a special shareholder meeting to discuss the activist investor’s demand to replace Depomed’s board.
** HALLIBURTON, Friday close $40.84, -0.22 pct premarket
The oilfield services provider pushes Q1 report to May 3 from April 25 to accommodate April 30 deadline to close acquisition of Baker Hughes. (Compiled by Rosmi Shaji in Bengaluru)